Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
ABSTRACT The fecal microbiota is a rich source of biomarkers that have previously been shown to be predictive of numerous disease states. Less well studied is the effect of immunomodulatory therapy on the microbiota and its role in response to therapy. This study explored associations between the fe...
Guardado en:
Autores principales: | Matthew K. Doherty, Tao Ding, Charlie Koumpouras, Shannon E. Telesco, Calixte Monast, Anuk Das, Carrie Brodmerkel, Patrick D. Schloss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1babf2df203b4e62b518a9c7af952e71 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern Iran
por: Seyed Alireza Taghavi, et al.
Publicado: (2013) - Journal of Crohn's and colitis
-
Physical Activity Shapes the Intestinal Microbiome and Immunity of Healthy Mice but Has No Protective Effects against Colitis in MUC2<sup>−/−</sup> Mice
por: Mehrbod Estaki, et al.
Publicado: (2020) -
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara T, et al.
Publicado: (2018) -
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
por: Kai Nie, et al.
Publicado: (2021)